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Gene 33/Mig6 Regulates Apoptosis and the DNA Damage Response 
through Independent Mechanisms 
Cen Li, Soyoung Park, Xiaowen Zhang, Leonard M. Eisenberg, Hong Zhao, Zbigniew Darzynkiewicz, and Dazhong Xu 
Department of Pathology, Department of Physiology, New York Medical College, Valhalla, New York 
Gene 33 (Mig6, ERRFI1) is an inducible adaptor/scaffold 
protein whose expression can be induced by both stress 
and mitogenic signals. It contains multiple domains for 
protein-protein interaction and is involved in a broad 
spectrum of cellular functions. Gene 33 promotes 
apoptosis in a cell type-dependent manner. A recent study 
has linked Gene 33 to the DNA damage response (DDR) 
induced by hexavalent chromium [Cr(VI)]. Here we show 
that Gene 33 induces apoptosis via both c-Abl/p73 and 
EGFR/AKT-dependent pathways in lung epithelial and lung 
carcinoma cells. Ectopic expression of Gene 33 also 
triggers DDR in an ATM-dependent fashion and through 
pathways with or without association with apoptosis. We 
observed significant presence of Gene 33 in the nucleus 
and chromatin. We show that the nuclear localization of 
Gene 33 is dependent on its 14-3-3 binding domain. We 
find that the chromatin localization of Gene 33 is, at least in 
part, dependent on its EBD motif. Our data also show that 
Gene 33 may regulate chromatin targeting of c-Abl and 
EGFR. Moreover, we observed strong association of Gene 
33 with histone H2AX and that Gene 33 promotes 
interaction between ATM and histone H2AX without 
triggering DNA damage. Our study reveals novel nuclear 
functions of Gene 33, which mediate DDR and apoptosis 
through independent mechanisms. Given our previous 
finding that Gene 33 depletion promotes Cr(VI)-induced 
DNA damage, our data suggest that Gene 33 may foster 
DNA repair by activating DDR. 
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Figure 1. Linear structure of Gene 33. 
Figure 3. Wild type but not Gene 33Y356A modestly inhibits cell proliferation and triggers 
apoptosis. Cell counting and IB detecting the indicated proteins in A549 cells after infected with 
adenoviral vectors encoding β-Gal, wild type Gene 33, or EBD mutant (YA) Gene 33. Laser scanning 
cytometry measuring cell cycle distributions of A549 and BEAS-2B cells after infected with the adenoviral 
vectors.     
Figure 4. Ectopic expression of Gene 33 induces apoptosis in 
an EBD-dependent but p53-independent manner and provokes 
DDR in an EBD-independent fashion. IB detecting the indicated 
proteins in A549 and BEAS-2B cells infected with the indicated 
adenoviral vectors, and in 293T cells transfected with the indicated 
expression plasmids. 
Figure 6. Nuclear localization of Gene 33. Cell fractionation assay on  A549 (left) 
BEAS-2B (middle) cells with or without infected with the indicated adenoviral vectors. 
T: total, C: cytoplasm, N: nucleus, Ch: chromatin, Gene 33YA: Gene 33 EBD mutant, 
S: short exposure, L: long exposure, Mig6: Mig6 antibody. Right: confocal imaging 
showing nuclear signals of Gene 33. 
Figure 8. Gene 33 binds to histone H2AX and promotes interaction between ATM and histone 
H2AX. BEAS-2B cells were infected with the indicated adenoviral vectors followed by IP and IB as 
indicated. Far right:  293T cells were transfected with expression plasmids encoding FLAG-tagged 
wild type Gene 33 or Gene 33 with EBD mutation (Gene 33YA) with or without co-transfection of 
His-tagged ATM followed by HIS pulldown and IB as indicated.   
Endogenous  
Confocal images of BEAS-2B 
cells ectopically expressing 
FLAG-tagged wild type or 1-
308AA of Gene33. green: 
FLAG, blue: DAPI. 
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Figure 5. Gene 33 induces apoptosis in a c-Abl/p73-dependent and DDR in an ATM-dependent 
fashion. A549 or BEAS-2B cells were infected with the indicated  adenoviral vectors and treated with the 
c-Abl inhibitor Nilotinib (Nilo), the EGFR kinase inhibitor AG1478 (AG), the ATM/ATR inhibitor caffeine 
(Caf), or the ATM kinase inhibitor KU55933 (KU). The indicated proteins were detected by IB.  
A549 
Figure 7. Ectopic expression 
of Gene 33 does not trigger 
DNA damage. A549 cells were 
either untreated (Control), or 
treated with UV for 30s and 
then recovered for 2h (UV), or 
infected with the indicated 
adenoviral vectors for 24h. 
Cells were then used to detect 
DNA damage by the comet 
assay. Representative images 
of the comet assay were 
shown and the DNA damage 
index (percentage of DNA in 
tail) was determined using the 
the OpenComet comet assay 
software (*P < 0.05).   
* 
Figure 9. A proposed model on the 
regulation of apoptosis and DDR by Gene 
33. Gene 33 binds and activates c-Abl 
thereby triggering the p73-dependent pro-
apoptotic pathway. Gene 33 may also 
promote apoptosis by inhibiting EGFR and 
AKT-mediated pro-survival pathway. Both of 
these pathways are dependent the EBD motif 
of Gene 33. Gene 33 activates DDR 
(manifested as γH2AX) via both a c-Abl/EBD-
dependent pathway and a c-Abl/EBD-
independent pathway through direct 
activation of c-Abl and promoting ATM-
histone H2AX interaction, respectively. Both 
pathways are dependent on ATM to activate 
DDR. Apoptosis- and DDR-associated 
activities of Gene 33 occur, at least in part, in 
the nucleus and/or chromatin.   
C: cytoplasm, N: nucleus.   
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Figure 2. A potential role of Gene 33 in Cr(VI)-induced lung 
carcinogenesis.  Cr(VI) reduces the levels of Gene 33 mRNA and 
Protein, which inhibits Cr(VI)-induced DNA damage that lead to 
genomic instability, cell transformation and carcinogenesis. 
